11/19
08:20 am
rani
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
11/14
03:34 pm
rani
Rani Therapeutics GAAP EPS of -$0.24 in-line [Seeking Alpha]
Low
Report
Rani Therapeutics GAAP EPS of -$0.24 in-line [Seeking Alpha]
11/14
08:12 am
rani
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update [Yahoo! Finance]
Medium
Report
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update [Yahoo! Finance]
11/14
08:00 am
rani
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
Medium
Report
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
11/7
04:18 pm
rani
Rani Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Rani Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/7
04:05 pm
rani
Rani Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
Rani Therapeutics to Participate in Upcoming Investor Conferences
10/18
08:33 am
rani
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
10/17
08:00 am
rani
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
Medium
Report
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
10/15
12:37 pm
rani
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering [Seeking Alpha]
High
Report
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering [Seeking Alpha]
10/15
08:30 am
rani
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
High
Report
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
10/13
06:07 am
rani
Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
High
Report
Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
10/9
07:54 am
rani
Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock [Yahoo! Finance]
Medium
Report
Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock [Yahoo! Finance]
10/8
04:05 pm
rani
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
Medium
Report
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit